Cargando…
The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of established HF risk factors, such as hypertension, diabetes...
Autores principales: | Abovich, Arielle, Matasic, Daniel S., Cardoso, Rhanderson, Ndumele, Chiadi E., Blumenthal, Roger S., Blankstein, Ron, Gulati, Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457686/ https://www.ncbi.nlm.nih.gov/pubmed/37637197 http://dx.doi.org/10.1016/j.ajpc.2023.100527 |
Ejemplares similares
-
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022) -
Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022) -
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
por: Bozkurt, Biykem, et al.
Publicado: (2020) -
Regulatory RNAs in Heart Failure
por: Gomes, Clarissa Pedrosa da Costa, et al.
Publicado: (2020) -
ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease
por: Winchester, David E., et al.
Publicado: (2023)